Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study

Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study

Abstract Background Little is known on how denosumab reduces skeletal-related events (SREs) by bone metastases from solid tumors. We sought to evaluate the effect of denosumab administration in patients with bone metastases from solid tumors. Methods Data of patients treated with denosumab were coll...

Full description

Bibliographic Details
Main Authors: Kohei Mizuta, Hiromichi Oshiro, Ryo Katsuki, Yuichi Tsuha, Yusuke Aoki, Yasunori Tome, Kotaro Nishida
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Cancer
Subjects:
Bone metastases
Denosumab
Skeletal-related events
Spinal instability neoplastic score
Mirels’ score
Online Access:https://doi.org/10.1186/s12885-023-11495-w

Similar Items

Similar Items